Temporal interference stimulation for depressive disorder
Official title: Intervention Effect of Temporal Interference Stimulation (TIS) on Depressive Disorder
Run by The Second Hospital of Anhui Medical University · NCT07191392 · Data updated 2026-11-12
This test tries to see if temporal interference stimulation (TIS) can improve associative memory in adults with depressive disorder.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 60 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | The Second Hospital of Anhui Medical University Academic / other |
| Locations | 2 sites (Hefei, Anhui and 1 other locations) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | June 2026 |
| Study ends | June 2026 |
| Registry record updated | March 10, 2026 |
| Trial ID | NCT07191392 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with DSM‑5 depressive disorder (HAMD>17, BSS>6, PHQ‑15>5), right‑handed, with at least five years of education and normal or corrected vision who can attend study visits are ideal candidates.
✕Probably not a fit
People with severe heart, liver, or renal disease, major neurological disorders (e.g., stroke, epilepsy), comorbid psychotic or substance‑use disorders, pregnant or breastfeeding women, or those outside the 18–65 age range are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Thirty adults with DSM‑5 diagnosed depressive disorder will receive either a 30‑minute session of temporal interference stimulation (TIS) or a sham TIS, with thirty matched healthy controls included for comparison. Participants complete neuropsychological assessments (including HAMD, HAMA, PHQ‑15, BSSI, PSQI, RRS, and others) and multimodal MRI (3D‑T1, resting‑state fMRI, and DTI) before and after the intervention. An incidental memory task using emotional pictures is used to measure associative memory changes pre‑ and post‑treatment. Clinical and imaging measures are compared between active and sham stimulation groups and against healthy controls.
Why it matters
Potential benefit: If successful, TIS could improve associative memory and related depressive symptoms and provide a noninvasive treatment option.
How similar studies have gone: TIS is a novel neuromodulation method with limited human efficacy data, although related noninvasive techniques like TMS and tDCS have shown modest benefits for depression and cognition.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * the patients were diagnosed by more than 2 psychiatrists and met the diagnostic criteria of DSM-5 for depression, and HAMD\>17, BSS\>6, PHQ-15\>5. * the age ranged from 18 to 65 years old, and the length of education was more than 5 years. * the visual acuity or corrected visual acuity is normal, right-handed, can cooperate with the completion of various experimental tests. Exclusion Criteria: * accompanied by severe somatic diseases, such as severe heart, liver, renal insufficiency and so on. * accompanied by other neurological diseases, such as stroke, epilepsy and so on. pregnant and lactating women. * accompanied by other mental disorders, such as drug abuse, schizophrenia, schizophrenic affective
Where it's running
-
Anhui Medical University
Hefei, Anhui, China Recruiting -
Anhui Mental Health Center
Hefei, Anhui, China Recruiting
Study contacts
- Study coordinator: Yanghua Tian, PhD
- Email: zylykd@163.com
- Phone: 0551 6599 7278
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
Aerobic Exercise as an Adjunct Therapy for Depression
This study tests whether adding a structured aerobic exercise program to standard antidepressant and therapy helps reduce depression severity more than standard care alone.
-
Group Unified Protocol for Emotional Disorders in adults in public mental health (UP in Spanish)
A group-based Spanish version of the Unified Protocol is being tested with adults in public mental health to see if it helps anxiety, depression, and related symptoms.
-
Metformin added to antidepressants for depression with obesity in Pakistani adults
This study tests whether adding metformin to antidepressant therapy helps reduce depressive symptoms and BMI in adults with depression and overweight/obesity in Pakistan.
-
Parent group program using the Unified Protocol for teens with autism and anxiety/depression
This trial tests a parent-guided adaptation of the Unified Protocol to help adolescents with autism and co-occurring anxiety or depression.
-
Temporal interference stimulation for non‑suicidal self‑injury in adolescent depression
This trial will test whether temporal interference stimulation (TIS) can reduce non‑suicidal self‑injury in adolescents and young adults (ages 12–22) with major depressive disorder compared with a sham treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.